Masaki Shiota, MD, PHD

Disclosure information not submitted.

Presentation(s):

• PD07-03: An oral first-in-class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer

  Friday, May 13, 2022
  9:50 AM – 10:00 AM

• PD35-10: Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer

  Sunday, May 15, 2022
  8:30 AM – 8:40 AM